In Re: Regeneron Pharmaceuticals, Inc.

1:25-cv-00017 | Delaware District Court

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Division Wilmington
Judge Judge Maryellen Noreika
Filed Jan. 6, 2025
Nature of Suit 890 Statutory Actions - Other
Cause 28:1782 Letter rogatory - appointment
Jury Demand None
Last Updated: 1 week, 4 days ago Show Interactive Timeline
Filing Date # Docket Text
3/3/2025REDACTED VERSION of 27 Reply to Response to Motion by Regeneron Pharmaceuticals, Inc.. (Vavala, Donald) (Entered: 03/03/2025)
2/25/2025 Letter to The Honorable Maryellen Noreika from Brian P. Egan regarding Amgen's response to Regeneron's February 25, 2025 letter (D.I. 30) - re 30 Letter,,. (Attachments: # 1 Exhibit A)(Egan, Brian) (Entered: 02/25/2025)
2/25/2025 Letter to The Honorable Maryellen Noreika from David E. Wilks regarding requests that the Court accept Applicant Regeneron Pharmaceuticals, Inc.'s Memorandum of Law in Response to Amgen Inc.'s Opposition to Regeneron's Ex Parte Application for an Order pursuant to 28 U.S.C. Section 1782 to take Discovery for use in Foreign Proceeding as filed and grant its Ex Parte Application - re 27 Reply to Response to Motion, 1 MOTION for Issuance of Letters Rogatory. (Wilks, David) (Entered: 02/25/2025)
2/24/2025 DECLARATION of Daryl Ong Hock Chye in Support of Memorandum of Law in Response to Amgen Inc.'s Opposition to Regeneron's Ex Parte Application for an Order pursuant to 28 U.S. C Section 1782 to take Discovery for use in Foreign Proceedings re 27 Reply to Response to Motion by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1-3)(Vavala, Donald) (Entered: 02/24/2025)
2/24/2025 DECLARATION of James S.S. Holtom in Support of Applicant Regeneron Pharmaceuticals, Inc.'s Ex Parte Application for an Order pursuant to 28 U.S.C. Section 1782 to take Discovery for use in Foreign Proceedings re 27 Reply to Response to Motion by Regeneron Pharmaceuticals, Inc.. (Vavala, Donald) (Entered: 02/24/2025)
2/24/2025
  • Reply
[SEALED] REPLY to Response to Motion re 1 MOTION for Issuance of Letters Rogatory filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Certificate of Service)(Vavala, Donald) (Entered: 02/24/2025)
2/24/2025
  • Motion to File
SO ORDERED re 26 Unopposed MOTION to File Under Seal. ORDERED by Judge Maryellen Noreika on 2/24/2025. (dlw) (Entered: 02/24/2025)
2/24/2025
  • Motion to File
Unopposed MOTION to File Under Seal - filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 D. DEL. LR 7.1.1 Certification)(Vavala, Donald) (Entered: 02/24/2025)
2/13/2025REDACTED VERSION of 18 Declaration by Amgen Inc.. (Egan, Brian) (Entered: 02/13/2025)
2/13/2025REDACTED VERSION of 17 Declaration by Amgen Inc.. (Egan, Brian) (Entered: 02/13/2025)
2/13/2025REDACTED VERSION of 16 Declaration by Amgen Inc.. (Egan, Brian) (Entered: 02/13/2025)
2/13/2025REDACTED VERSION of 14 Answering Brief in Opposition by Amgen Inc.. (Egan, Brian) (Entered: 02/13/2025)
2/11/2025 Letter to The Honorable Maryellen Noreika from David E. Wilks regarding Response to Amgen Inc.'s February 7, 2025 filing - re 14 Answering Brief in Opposition. (Wilks, David) (Entered: 02/11/2025)
2/10/2025
  • Motion to Seal
SO ORDERED re 13 Unopposed MOTION to Seal. ORDERED by Judge Maryellen Noreika on 2/10/2025. (dlw) (Entered: 02/10/2025)
2/7/2025 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Amgen Inc.. (Egan, Brian) (Entered: 02/07/2025)
2/7/2025 DECLARATION of Abraham Vergis re 14 Answering Brief in Opposition by Amgen Inc.. (Attachments: # 1 Exhibits 1-2, # 2 Exhibits 3-7, # 3 Exhibits 9-16)(Egan, Brian) (Entered: 02/07/2025)
2/7/2025[SEALED] DECLARATION of Marc Doble re 14 Answering Brief in Opposition by Amgen Inc.. (Egan, Brian) (Entered: 02/07/2025)
2/7/2025[SEALED] DECLARATION of Natalia Gomez re 14 Answering Brief in Opposition by Amgen Inc.. (Egan, Brian) (Entered: 02/07/2025)
2/7/2025[SEALED] DECLARATION of Angel Santiago-Lopez re 14 Answering Brief in Opposition by Amgen Inc.. (Egan, Brian) (Entered: 02/07/2025)
2/7/2025 DECLARATION of Brian P. Egan re 14 Answering Brief in Opposition by Amgen Inc.. (Attachments: # 1 Exhibits 1-5)(Egan, Brian) (Entered: 02/07/2025)
2/7/2025[SEALED] ANSWERING BRIEF in Opposition re 1 MOTION for Issuance of Letters Rogatory filed by Amgen Inc..Reply Brief due date per Local Rules is 2/14/2025. (Egan, Brian) (Entered: 02/07/2025)
2/7/2025
  • Motion to Seal
Unopposed MOTION to Seal - filed by Amgen Inc.. (Attachments: # 1 Text of Proposed Order)(Egan, Brian) (Entered: 02/07/2025)
1/27/2025 Letter to The Honorable Maryellen Noreika from David E. Wilks regarding response to Amgen Inc.'s letter dated January 24, 2025 - re 11 Letter. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Wilks, David) (Entered: 01/27/2025)
1/24/2025 Letter to The Honorable Maryellen Noreika from Brian P. Egan regarding follow-up to January 8, 2025 - re 9 Letter. (Attachments: # 1 Exhibit A)(Egan, Brian) (Entered: 01/24/2025)
1/24/2025 NOTICE of Appearance of Brian P. Egan, Megan E. Dellinger, and Cameron P. Clark by Amgen Inc. (Egan, Brian) (Entered: 01/24/2025)
1/9/2025Pro Hac Vice Attorney Jonathan D. Loeb,Luke M. Reilly,Katherine A. Helm,Sharon K. Gagliardi,Charles Hsu for Regeneron Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (scs) (Entered: 01/09/2025)
1/8/2025Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) (Entered: 01/08/2025)
1/8/2025 Letter to The Honorable Maryellen Noreika from Brian P. Egan regarding § 1782 Application - re 1 MOTION for Issuance of Letters Rogatory. (Egan, Brian) (Entered: 01/08/2025)
1/8/2025
  • Motion to Appear Pro Hac Vice
SO ORDERED re 6 MOTION for Pro Hac Vice Appearance of Attorney Katherine A. Helm, Ph.D., 7 MOTION for Pro Hac Vice Appearance of Attorney Sharon K. Gagliardi and Luke M. Reilly, 8 MOTION for Pro Hac Vice Appearance of Attorney Jonathan Loeb, Ph.D. and Charles Hsu filed by Regeneron Pharmaceuticals, Inc. ORDERED by Judge Maryellen Noreika on 1/8/2025. (dlw) (Entered: 01/08/2025)
1/7/2025
  • Motion to Appear Pro Hac Vice
MOTION for Pro Hac Vice Appearance of Attorney Jonathan Loeb, Ph.D. and Charles Hsu - filed by Regeneron Pharmaceuticals, Inc.. (Vavala, Donald) (Entered: 01/07/2025)
1/7/2025
  • Motion to Appear Pro Hac Vice
MOTION for Pro Hac Vice Appearance of Attorney Sharon K. Gagliardi and Luke M. Reilly - filed by Regeneron Pharmaceuticals, Inc.. (Vavala, Donald) (Entered: 01/07/2025)
1/7/2025
  • Motion to Appear Pro Hac Vice
MOTION for Pro Hac Vice Appearance of Attorney Katherine A. Helm, Ph.D. - filed by Regeneron Pharmaceuticals, Inc.. (Vavala, Donald) (Entered: 01/07/2025)
1/7/20255Pro Hac Vice Fee - Credit Card Payment received for Katherine A. Helm, Ph.D, Sharon K. Gagliardi, Luke M. Reilly, Jonathan Loeb, Ph.D., and Charles Hsu. ( Payment of $ 250, receipt number ADEDC-4584503).(Vavala, Donald) (Entered: 01/07/2025)
1/6/2025No Summons Issued. (mpb) (Entered: 01/07/2025)
1/6/2025 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Regeneron Pharmaceuticals, Inc. (mpb) (Entered: 01/07/2025)
1/6/2025 MEMORANDUM in Support of 1 Ex Parte Application for an Order Pursuant to 27 U.S.C. § 1782 to Take Discovery for Use in Foreign Proceedings - filed by Regeneron Pharmaceuticals, Inc. Answering Brief/Response due date per Local Rules is 1/21/2025. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(mpb) (Entered: 01/07/2025)
1/6/2025Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 01/07/2025)
1/6/2025
  • Motion
Ex Parte Application for an Order Pursuant to 27 U.S.C. § 1782 to Take Discovery for Use in Foreign Proceedings (Filing fee $ 405, receipt number ADEDC-4583273) - filed by Regeneron Pharmaceuticals, Inc. (Attachments: # 1 Proposed Order, # 2 Civil Cover Sheet)(mpb) (Entered: 01/07/2025)